Targeted therapy in patients with PIK3CA-related overgrowth syndrome - Nature

Clicks: 166
ID: 270255
2018
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A PI3KCA inhibitor reverses symptoms in a mouse model of PROS/CLOVES syndrome, which results from gain-of-function mutations in PI3KCA, and produces improvements in patients with PROS/CLOVES syndrome.
Reference Key
quitterie2018naturetargeted Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Venot, Quitterie;Blanc, Thomas;Rabia, Smail Hadj;Berteloot, Laureline;Ladraa, Sophia;Duong, Jean-Paul;Blanc, Estelle;Johnson, Simon C.;Hoguin, Clément;Boccara, Olivia;Sarnacki, Sabine;Boddaert, Nathalie;Pannier, Stephanie;Martinez, Frank;Magassa, Sato;Yamaguchi, Junna;Knebelmann, Bertrand;Merville, Pierre;Grenier, Nicolas;Joly, Dominique;Cormier-Daire, Valérie;Michot, Caroline;Bole-Feysot, Christine;Picard, Arnaud;Soupre, Véronique;Lyonnet, Stanislas;Sadoine, Jeremy;Slimani, Lotfi;Chaussain, Catherine;Laroche-Raynaud, Cécile;Guibaud, Laurent;Broissand, Christine;Amiel, Jeanne;Legendre, Christophe;Terzi, Fabiola;Canaud, Guillaume;Venot, Quitterie;Blanc, Thomas;Rabia, Smail Hadj;Berteloot, Laureline;Ladraa, Sophia;Duong, Jean-Paul;Blanc, Estelle;Johnson, Simon C.;Hoguin, Clément;Boccara, Olivia;Sarnacki, Sabine;Boddaert, Nathalie;Pannier, Stephanie;Martinez, Frank;Magassa, Sato;Yamaguchi, Junna;Knebelmann, Bertrand;Merville, Pierre;Grenier, Nicolas;Joly, Dominique;Cormier-Daire, Valérie;Michot, Caroline;Bole-Feysot, Christine;Picard, Arnaud;Soupre, Véronique;Lyonnet, Stanislas;Sadoine, Jeremy;Slimani, Lotfi;Chaussain, Catherine;Laroche-Raynaud, Cécile;Guibaud, Laurent;Broissand, Christine;Amiel, Jeanne;Legendre, Christophe;Terzi, Fabiola;Canaud, Guillaume;
Journal Nature
Year 2018
DOI
doi:10.1038/s41586-018-0217-9
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.